6 April 2026

Last updated: Sunday 5 April 2026

Research Directory

Stock values decline and companies restructure

Adrenomed prepares global study in septic shock

Oncology pipeline marked by multiple therapy types

Targeting skeletal muscle to treat type 2 diabetes

After three years of Covid, risks to health remain

Immunocore and Gadeta probe gamma delta T cell receptors

Novel oncology drugs approved in a year of change

Q4 2022 Stock Comment

Climate change is transforming infectious disease

Regulatory framework for real-world data progresses